Yahoo Finance21d
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...
Morningstar21d
AbbVie Gets CHMP Backing of Rinvoq in Giant Cell Arteritis
The North Chicago, Ill., biopharmaceutical company said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the first half of the year.
Zacks.com on MSN5mon
Novartis Gets CHMP Recommendation for Kisqali in Broader Population
The CHMP adopted a positive opinion for the marketing authorization for Kisqali for the adjuvant treatment of adults with ...
Nasdaq1mon
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
(RTTNews) - AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy for limited-stage small cell lung cancer.
BioWorld21d
Leqembi gets another thumbs-up amid CHMP February recommendations
The EMA’s Committee for Medicinal products for Human Use (CHMP) is standing by its opinion on Leqembi (lecanemab) after the European .mission pushed back against a recommendation in November 2024 that ...
Morningstar21d
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Viehbacher, "Biogen") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...